| Impact of TMP-SMX Prophylaxis on Malaria Infection and Immunity in Children in Uganda (NCT02094508) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-03-07 |
| Safety And Immunogenicity Of Novel Candidate Blood-Stage Malaria Vaccine P27A : Phase Ia/Ib (NCT01949909) | Centre Hospitalier Universitaire Vaudois | 2014-03-01 |
| Clinical and Biological Efficacy of Mirasol-treated Fresh Whole Blood for the Prevention of Transfusion-transmitted Malaria (NCT02118428) | Terumo BCTbio | 2014-03-01 |
| A Phase I Study to Assess the Safety and Immunogenicity of ChAd63 ME-TRAP - MVA ME-TRAP Heterologous Prime-boost Vaccination Co-administered With EPI Vaccines in Gambian Infants (NCT02083887) | University of Oxford | 2014-02-01 |
| School-Based Treatment With ACT to Reduce Transmission (NCT02009215) | London School of Hygiene and Tropical Medicine | 2014-02-01 |
| Trial to Compare Effectiveness of 2 Insecticides in Preventing Malaria (NCT02458066) | Medical Care Development, Inc. | 2014-02-01 |
| Plasmodium Vivax Efficacy Trial in Cruzeiro do Sul, Acre, Brazil (NCT02043652) | Centers for Disease Control and Prevention | 2014-02-01 |
| Immunization Via Mosquito Bite With Radiation-attenuated Sporozoites (NCT01994525) | U.S. Army Medical Research and Development Command | 2014-01-24 |
| A Study to Find the Minimum Inhibitory Concentration of KAE609 in Adult Male Patients With P. Falciparum Monoinfection (NCT01836458) | Novartis Pharmaceuticals | 2014-01-01 |
| Evaluating the Ottawa Malaria Decision Aid (NCT01976325) | Ottawa Hospital Research Institute | 2014-01-01 |
| Study of Controlled Human Malaria Infections to Evaluate Protection After Intravenous or Intramuscular Administration of PfSPZ Vaccine in Malaria-Naive Adults (NCT02015091) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-12-12 |
| Efficacy and Bio-availability of Artemether-Lumefantrine in Severely Malnourished Children (NCT01958905) | Epicentre | 2013-11-01 |
| Community Point Distribution of Insecticide Treated Bed Nets (NCT02517879) | IDinsight | 2013-11-01 |
| Study of Safety and Effectiveness of Intravenous Immunization With PfSPZ Vaccine in Healthy African Adults (NCT01988636) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-10-29 |
| Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa (NCT01954264) | GlaxoSmithKline | 2013-10-19 |
| Harmonized AS/MQ Efficacy Study - Thailand (NCT02052323) | Armed Forces Research Institute of Medical Sciences, Thailand | 2013-10-01 |
| Safety and Immunogenicity of Plant-Derived Pfs25 VLP-FhCMB Malaria Transmission Blocking Vaccine in Healthy Adults (NCT02013687) | Fraunhofer, Center for Molecular Biotechnology | 2013-10-01 |
| Open Label Pharmacokinetic Study of OZ439 and Piperaquine on Administration of OZ439+TPGS Granules for Oral Suspension Alone or With Either Piperaquine Phosphate Tablets or Granules for Oral Solution in Healthy Volunteers (NCT01958619) | Medicines for Malaria Venture | 2013-10-01 |
| Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Uncomplicated Malaria in South Kivu, DR Congo (NCT02741024) | Medecins Sans Frontieres, Netherlands | 2013-10-01 |
| Adherence to Antimalarial Drugs in Sierra Leone (NCT01967472) | London School of Hygiene and Tropical Medicine | 2013-09-16 |
| Evaluation of Oral Activated Charcoal on Antimalarial Drug's Ability to Kill Parasites in Malian Children With Malaria (NCT01955382) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-09-01 |
| Low Dose Primaquine for Clearance of Gametocytes (NCT01935882) | London School of Hygiene and Tropical Medicine | 2013-09-01 |
| Phase2a Primaquine Dose Escalation Study (NCT01743820) | University of California, San Francisco | 2013-09-01 |
| Introduction of Eurartesim® in Burkina Faso, Mozambique, Ghana and Tanzania (NCT02199951) | INDEPTH Network | 2013-09-01 |
| A Trial of the Efficacy of Artesunate and Three Quinine Regimens in the Treatment of Severe Malaria in Children at the Ebolowa Regional Hospital - Cameroon (NCT02563704) | University of Yaounde 1 | 2013-09-01 |
| Studies of a Candidate Aminoquinoline Antimalarial (AQ-13) (NCT01614964) | Tulane University | 2013-08-01 |
| Primaquine's Gametocytocidal Efficacy in Malaria Asymptomatic Carriers (NCT01838902) | London School of Hygiene and Tropical Medicine | 2013-08-01 |
| Clinical Performance Evaluation of Fyodor Urine Malaria Test (UMT) (NCT01921413) | Fyodor Biotechnologies Inc | 2013-07-01 |
| Malaria Survey in the Tak Province Refugee Camps (NCT01902797) | University of Oxford | 2013-07-01 |
| Comparison of Two Regimens of Artemether-lumefantrine for the Treatment of Malaria in Pregnancy (NCT01916954) | University of Oxford | 2013-07-01 |
| Acute vs. Delayed Iron: Effect on Red Cell Iron Incorporation in Severe Malaria (NCT01754701) | University of Minnesota | 2013-06-01 |
| A Phase I Clinical Trial Immunizing Healthy Adults With the NMRC-M3V-Ad-PfCA Vaccine to Generate Biologic Reagents (NCT01843491) | U.S. Army Medical Research and Development Command | 2013-06-01 |
| Surveillance and Treatment With Dihydroartemisinin-piperaquine Plus Primaquine (NCT01878357) | Indonesia University | 2013-06-01 |
| Optimal Fluid Management in Adult Severe Malaria (NCT01936766) | University of Oxford | 2013-05-01 |
| Relative Bioavailability of Pyronaridine-artesunate in Tablet and Granule Formulations in Healthy Volunteers (NCT01868438) | Medicines for Malaria Venture | 2013-05-01 |
| TES of Artemether-lumefantrine for Pf and Chloroquine for Pv in the Philippines From 2013-2014 (NCT04222088) | Research Institute for Tropical Medicine, Philippines | 2013-05-01 |
| Safety and Efficacy of Primaquine for P. Vivax (NCT01837992) | Menzies School of Health Research | 2013-05-01 |
| ICCM of Common Childhood Diseases: Mozambique and Uganda (NCT01972321) | Malaria Consortium | 2013-04-01 |
| Pharmacokinetic Study of Multi-dose Chloroquine (NCT01814423) | Bandim Health Project | 2013-04-01 |
| Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy 2 (TRANSACT2) (NCT01939886) | London School of Hygiene and Tropical Medicine | 2013-04-01 |
| Healthy Volunteer Study of the Pharmacokinetics of Oral Piperaquine With OZ439 + TPGS Formulation in the Fasted State (NCT01853475) | Medicines for Malaria Venture | 2013-04-01 |
| Phase Ia Study of ChAd63/MVA PvDBP (NCT01816113) | University of Oxford | 2013-04-01 |
| Evaluation of the Efficacy of Artemisinin Combination Therapy in Kenya (NCT01899820) | Sabah Ahmed Omar | 2013-04-01 |
| Impact Evaluation of Community-Based Health Programs in Rwanda (NCT01836731) | Georgetown University | 2013-04-01 |
| Testing Pfs25-EPA/Alhydrogel as a Potential Malaria Transmission Blocking Vaccine (NCT01867463) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-03-27 |
| OZ439 PhIIa Study in Plasmodium Falciparum: Extended Observation (NCT01713621) | Medicines for Malaria Venture | 2013-03-01 |
| Intravenous Artesunate and Malaria (NCT01805232) | University of Khartoum | 2013-03-01 |
| Efficacy, Safety, Tolerability and Pharmacokinetics of KAF156 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infection (NCT01753323) | Novartis Pharmaceuticals | 2013-03-01 |
| Collection of Biological Material From Pregnant Women in a Malarial Region (NCT01862783) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-02-10 |
| Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever) (NCT01766830) | University Hospital, Geneva | 2013-01-01 |
| Impact of Repeated Anthelmintic Treatment on the Risk of Malaria in Kenyan School Children (NCT01658774) | London School of Hygiene and Tropical Medicine | 2013-01-01 |
| Trial of Artemether-Lumefantrine Alone and in Combination With Ivermectin to Reduce Post-Treatment Malaria Transmission (NCT01603251) | London School of Hygiene and Tropical Medicine | 2013-01-01 |
| Optimization of Controlled Human Malarial Infection by Injection of P. Falciparum Sporozoites in Non-Immune Adults (NCT01771848) | Sanaria Inc. | 2012-12-01 |
| A Phase 1/2b Study of an Investigational Malaria Vaccination Strategy in 5-17 Month Old Infants and Children in Burkina Faso (NCT01635647) | University of Oxford | 2012-11-01 |
| Improving Anti-malarial Treatment Options in Guinea-Bissau - Part A (NCT01704508) | Bandim Health Project | 2012-11-01 |
| A Dose-escalation Study to Investigate Safety and Toleration of OZ439 (NCT01713608) | Medicines for Malaria Venture | 2012-11-01 |
| Amodiaquine-Artesunate & Artemether-Lumefantrine Efficacy in Burkina Faso (NCT01697787) | Centre Muraz | 2012-10-01 |
| Exposure of Naive and Pre-immune Subjects to P. Vivax Challenge (NCT01585077) | Socrates Herrera Valencia | 2012-10-01 |
| Sustainable Financial Incentives To Improve Prescription Practices For Malaria (NCT01809873) | Duke University | 2012-09-01 |
| Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis (NCT01728701) | Sanaria Inc. | 2012-09-01 |
| Effectiveness of OZ439 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Volunteers (NCT02453581) | Medicines for Malaria Venture | 2012-09-01 |
| Phase 1b Malaria Clinical Trial Using Argemone Mexicana in Healthy Adults in Mali (NCT01645254) | University of Bamako | 2012-09-01 |
| Efficacy of Intermittent Screening and Treatment or Intermittent Preventive Treatment (IPT) With Dihydroartemisinin-Piperaquine, Versus IPT With Sulfadoxine-Pyrimethamine for the Control of Malaria in Pregnancy in Kenya (NCT01669941) | Kenya Medical Research Institute | 2012-08-01 |
| Comparison of Three Plasmodium Falciparum Isolates in a Controlled Human Malaria Infection (NCT01627951) | Radboud University Medical Center | 2012-08-01 |
| Antimalarial Pharmacology in Children and Pregnant Women in Uganda (NCT01717885) | University of California, San Francisco | 2012-08-01 |
| Adjuvanting Viral Vectored Malaria Vaccines With Matrix M (NCT01669512) | University of Oxford | 2012-08-01 |
| Safety, Tolerability & Pharmacokinetics (PK) of Co-administered Single Doses of OZ439 and Mefloquine (MQ) in Healthy Volunteers (NCT01615822) | Medicines for Malaria Venture | 2012-08-01 |
| Efficacy of Candidate Malaria Vaccines in Senegalese Adults (NCT01658696) | University of Oxford | 2012-08-01 |
| ANC & Malaria Diagnostic in Pregnancy (NCT01703884) | Centre Muraz | 2012-08-01 |
| Paracetamol Effect on Oxidative Stress and Renal Function in Severe Malaria (NCT01641289) | University of Oxford | 2012-07-10 |
| Seasonal Malaria Chemoprevention Versus Home Management of Malaria in Children Under 5 Years in Ghana (NCT01651416) | Centre for Global Health Research, Ghana | 2012-07-01 |
| Immunization of Human Volunteers With P. Vivax Irradiated Sporozoites (NCT01082341) | Malaria Vaccine and Drug Development Center | 2012-06-01 |
| Controlled Human Malarial Infection by Intravenous Injection of Plasmodium Falciparum Sporozoites in Non-Immune Adults (NCT01624961) | Sanaria Inc. | 2012-06-01 |
| Impact of Artemisinin-based Combination Therapy and Quinine on Treatment Failure and Resistance in Uncomplicated Malaria (NCT01374581) | Universiteit Antwerpen | 2012-05-01 |
| Malaria Prevention Cambodia (NCT01624337) | Armed Forces Research Institute of Medical Sciences, Thailand | 2012-05-01 |
| Trial for Malaria Vaccine Candidate, PfPEBS (P. Falciparum Pre-Erythrocytic and Blood Stage) (NCT01605786) | Vac4All | 2012-05-01 |
| Repellents as Added Control Measure to Long Lasting Insecticidal Nets (NCT01663831) | Institute of Tropical Medicine, Belgium | 2012-05-01 |
| Reducing the Burden of Malaria by Targeting Hotspots of Malaria Transmission (NCT01575613) | Radboud University Medical Center | 2012-04-01 |
| Single Oral Dose Study of Atovaquone/Proguanil Hydrochloride Combination Tablets and Atovaquone Suspension (NCT01858831) | GlaxoSmithKline | 2012-04-01 |
| Sanaria™ PfSPZ Challenge Vaccine (NCT01546389) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-04-01 |
| Efficacy of Malaria Vaccines in Kenyan Adults (NCT01666925) | University of Oxford | 2012-03-01 |
| Can Mass Media Campaigns Reduce Child Mortality (NCT01517230) | London School of Hygiene and Tropical Medicine | 2012-03-01 |
| Effectiveness of Nutritional Supplementation in Preventing Malnutrition in Children With Infection (NCT01154803) | Medecins Sans Frontieres, Netherlands | 2012-02-01 |
| Chloroquine for Malaria in Pregnancy (NCT01443130) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-02-01 |
| Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya (NCT01425073) | University of Washington | 2012-02-01 |
| Trial of a Falciparum Malaria Protein (FMP012), E. Coli-expressed PfCelTOS, in Healthy Malaria-Naive Adults (NCT01540474) | U.S. Army Medical Research and Development Command | 2012-02-01 |
| Cluster Randomised Trial of Malaria RDTs Used by CHWs in Afghanistan (NCT01403350) | London School of Hygiene and Tropical Medicine | 2012-02-01 |
| Pharmacology of Antimalarial Therapy With or Without Antiretroviral Therapy (NCT01728961) | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 2012-02-01 |
| Controlled Human Malaria Infection by Intradermal Injection of Plasmodium Falciparum Sporozoites in Tanzanian Adults (NCT01540903) | Sanaria Inc. | 2012-02-01 |
| Efficacy, Safety, Tolerability and Pharmacokinetics of KAE609 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infection (NCT01524341) | Novartis Pharmaceuticals | 2012-01-01 |
| Drug Interaction Study of Pyronaridine-artesunate & Metoprolol, & Redosing Study of Pyronaridine-artesunate (NCT01523002) | Medicines for Malaria Venture | 2012-01-01 |
| Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine Versus Mefloquine Prophylaxis (NCT01422954) | Radboud University Medical Center | 2012-01-01 |
| Efficacy and Tolerability of Artesunate Amodiaquine Versus Chloroquine in the Treatment of Uncomplicated Plasmodium Vivax Malaria (NCT01378286) | Sanofi | 2012-01-01 |
| Apheresis to Obtain Plasma and White Blood Cells in Malies (NCT01511601) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-12-20 |
| Malaria Challenge in Healthy Volunteers (NCT01500980) | Seattle Children's Hospital | 2011-12-01 |
| Safety and Immunogenicity of New Malaria Vaccine Candidate ChAd63 CS Administered Alone and With MVA CS (NCT01450280) | University of Oxford | 2011-12-01 |
| Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049) (NCT01345240) | GlaxoSmithKline | 2011-11-17 |
| Intermittent Parasite Clearance (IPC) in Schools: Impact on Malaria, Anaemia and Cognition (NCT01454752) | London School of Hygiene and Tropical Medicine | 2011-11-01 |
| AdCh63 ME-TRAP and MVA ME-TRAP Malaria Vaccines Evaluation in Healthy Children in a Malaria Endemic Area (NCT01450293) | University of Oxford | 2011-10-01 |
| Anti-parasitic Activity and Safety Assessment of SAR97276A in Children With Uncomplicated Malaria (NCT01445938) | Sanofi | 2011-10-01 |